About us

The Cochrane Gynaecological, Neuro-oncology & Orphan Cancer Group (CGNOC) is part of Cochrane and its editorial base is in Bath, UK.

Cochrane is a not-for-profit organization with collaborators from more than 130 countries working together to produce credible, accessible health information in the form of systematic reviews that are free from commercial sponsorship and other conflicts of interest.  Many of our contributors are world leaders in their fields; medicine, health policy, research methodology, or consumer advocacy - and our groups are situated in some of the world's most respected academic and medical institutions.

Cochrane is for anyone who is interested in using high-quality information to make health decisions. Whether you are a doctor or nurse, patient or carer, researcher or funder, Cochrane evidence provides a powerful tool to enhance your healthcare knowledge and decision making.

We respond to the challenge of making the vast amounts of best available evidence generated through research useful for informing decisions about health. Our work is recognized as representing an international gold standard for high quality, trusted information.

CGNOC are committed to providing reliable evidence required to make important decisions on issues concerning Gynaecological cancers, Neuro-oncology and related topics.

CGNOC's main task is to facilitate the identification of reports of controlled clinical trials and to carry out systematic reviews which are then published on the Cochrane Library. The reviews are updated as new evidence is identified. This ensures that Cochrane reviews are relevant, useful, usable and used.

Evidence relating to the care of people with cancer comes from a number of sources and so a multi-faceted approach is taken, including searching electronic databases of clinical trial reports, handsearching printed journals, and scanning of the 'grey' literature i.e. conference proceedings and abstracts. Every effort is made to find unpublished trials to avoid bias.

The CGNOC links with other CGs to share ideas.  It also works with fields and methods working groups to ensure that its reviews are of the highest quality. CGNOG often has common areas of interest with other Cochrane Groups, notably Pain, Palliative and Supportive Care Group,  Menstrual Disorders and Subfertility Group and  all other Cochrane Groups with cancer in their scope.  Every effort is made to avoid duplication

We are pleased to offer translations in French, Spanish, Croatian and Portuguese. People who wish to search or browse in their own language can do so on Cochrane Summaries;

French - Français (http://summaries.cochrane.org/fr
provided by the French Cochrane Centre

Spanish - Español (http://summaries.cochrane.org/es)
provided by the Iberoamerican Cochrane Centre

Croatian – Hrvatski (http://summaries.cochrane.org/hr)
provided by the Croatian Cochrane Branch

Portuguese - Português (http://summaries.cochrane.org/pt)
provided by the Brazilian Cochrane Centre

--------------------------------------------------------------------------------------------------------------

National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Gynaecological, Neuro-oncology and Orphan Cancer group and provides core funding for the Editorial Base

-------------------------------------------------------------------------------

Cochrane Colloquium 2016 - Seoul